Abstract: A systematic and comprehensive phenotyping platform has been developed by the RIKEN ENU-mutagenesis project between 1999 and 2007. As a result of phenotype screening on this platform, we have discovered about 400 mutants as animal models for human diseases. All information regarding these mouse mutants is now available to the public through our home page (http://www.brc.riken.jp/lab/gsc/mouse/indexJ.html). In 2008, we reconstructed the existing phenotyping platform and built a new platform. The new system has a hierarchical structure, consisting of a fundamental pipeline that utilizes the existing platform and an additional pipeline, which is optimized for more in-depth phenotyping assays. Using this system, we have started to perform more comprehensive phenotyping of mouse mutants. We have opened this system to Japanese scientists as the Japanese Mouse Clinic. It is anticipated that existing mouse mutants will be reevaluated as disease models by identifying novel phenotypes on the new platform. We will share detailed information about the standard operating procedures (SOPs) of our phenotyping analyses with other related large-scale projects, such as the European Mouse Disease Clinic (EUMODIC) and the German Mouse Clinic (GMC). Moreover, we will contribute to international efforts to standardize mouse phenotype data by sharing annotation of mutant phenotypes, which are made by internationally standardized methods, with other related projects.
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Introduction
The mouse has served as an important model for human diseases such as neurological disorders, cancer, diabetes, hypertension, and various reproductive anomalies. As a disease model animal, it has a long history of study, and there exist various technologies for the experimental manipulation of its genome, including transgenesis, mu--ReviewReview Series: Animal Bioresource in Japan tagenesis, and gene targeting [4, 8] . Furthermore, the large collection of standardized classical inbred strains and controlled animal rearing environments enable us to use/advance genetic approaches and making to detect genetic factors responsible for even subtle phenotypes. The genetic factors affecting various traits can be further confi rmed by systematic change of environmental factors and genetic input to measure effects under defi ned conditions. Following the determination of the murine genome sequence, the International Knockout Mouse Consortium (IKMC) was launched to generate mutations for every gene in the mouse genome [1, 2, 7, 12] . As a next step in the determination of the genetic foundation of biological processes and diseases, systematic and comprehensive functional characterization of generated mutants is desirable. The mouse clinic system, a standardized and comprehensive phenotyping platform for analyzing mouse individuals, enables direct and highly accurate comparisons among the large number of mutants generated. It would be a great contribution to biomedical science with mouse models if these independent systems could combine their data and develop an integrated database of mouse phenotypes across diverse academia and industry groups [6] . In 2008, we constructed the comprehensive phenotyping system "the Japan Mouse Clinic" at the RIKEN BioResource Center as a concerted effort for the international mouse community.
Establishment of a System for the Japan Mouse Clinic
The Japan Mouse Clinic was constructed as a system to receive requests from the mouse community, perform comprehensive phenotypic examinations, analyze phenotypic data, and fi nally publish the data to a website (http//mouseclinic.brc.riken.jp/en) (Fig. 1) .
Construction of the Pipeline for "Fundamental
Screens" at the Japan Mouse Clinic A fundamental screening pipeline (pipeline 1 of the Japan Mouse Clinic) has been constructed using standard operating procedures and preparation of statistical methods. It consists of the open-fi eld test (at 7 weeks old), the modifi ed-SHIRPA (at 8 weeks old), hematological test (at 9 weeks old), urinalysis (at 10 weeks old), clinical biochemical test (at 11 weeks old), and pathology (at 26 weeks old). Also included are 'in-depth screening' by rota-rod test (at 12 weeks old), auditory brainstem response (ABR; at 13 weeks old), insulin tolerance test (ITT; at 13 weeks old), oral glucose tolerance test (OGTT; at 14 weeks old), blood lactate measurement (at 17 weeks old), adipocytokine and clinical biochemical tests (glucose and adipose related; at 18 weeks old), funduscopy (at 19 weeks old), electroretinography (ERG; at 20 weeks old), blood pressure (at 21 weeks old), analysis of body fat percentage and bone mineral density by dual-energy X-ray absorptiometry (DEXA; at 23 weeks old), and echocardiography (at 24 weeks) (Fig.  2) . For pipeline 1, 60 animals (10 mutant males, 10 mutant females, 10 heterozygous males, 10 heterozygous females, 10 male controls, and 10 female controls) are required.
Construction of the Pipeline for Behavior-Oriented Screening
In general, the results of behavioral analyses are in- The open-fi eld test is carried out in order to asses spontaneous activity in novel environment. Distance traveled and % time spent in the center area over 20 min are measured using a CCD camera and video imaging system as indexes of locomotor activity and emotionality.
2) Modifi ed-SHIRPA. The modifi ed-SHIRPA is a simple method for evaluating the characteristic behaviors and morphologies of mice. Fifty-three items of various mouse behaviors, morphologies, and sensory responses are tested by visual inspection and manual handling using simple equipment.
3) Hematological test. The hematological test: 15 parameters are measured by an automatic hematology analyzer (ADVIA120, SIEMENS). 4) Urinalysis. Urine tests are performed using dip sticks. The test items are glucose, protein, bilirubin, urobilinogen, pH, occult body, and ketone body. 6) Macroscopic test. Pathological analyses commence at and weeks continue until 26 weeks of age.
7) Rota-rod test. Motor coordination, balance and motor learning abilities are examined with rota-rod apparatus. 8) ABR (Auditory brainstem response). Measurement of ABR provides a quantitative index for auditory functions. 9) ITT (Insulin tolerance test). ITT measures the degree of insulin resistance of the mice tested. 10) OGTT (Oral glucose tolerance test). The glucose tolerance test measures the clearance of a standardized glucose load from the body. 11) Lactate measurements in blood. Blood lactate is measured by a lactate test meter (Lactate Pro) for inspection of the metabolism of the muscle. 12) Adipocytokine and clinical biochemical test. Eleven adipocytokines are analyzed by a multiplex suspension array system for glucose and lipid metabolism. 13) Funduscopy. Mouse retinal morphology is observed through a funduscope camera. 14) ERG (Electroretinography). Retinal functions with light stimulus are examined. Amplitudes of currents that fl ow from the retina with light stimulus in darkness are measured.
15) Blood pressure. Non-invasive blood pressure measurement is performed with near-infrared photometry to monitor pulse waves through tail tissues. Tail-cuffs automatically apply exogenous pressure. 16) Body fat percentage and bone mineral density (DEXA). The body fat percentage (%Fat) and bone mineral density (BMD) are measured simultaneously by the DEXA method (dual-energy X-ray absorptiometry). 17) Echocardiography. Ultrasound is applied to the thorax and the refl ection data are computed to draw an echocardiogram. fl uenced by pretest experience. Additionally, a multidirectional assay platform is necessary to assess behavioral characteristics. Thus, we constructed pipeline 2, which is directed at behavioral characterization. Pipeline 2 is composed of behavioral test batteries A and B. Test battery A is a comprehensive behavioral assay platform which includes a light/dark transition test (at 8 weeks old), an open-fi eld test (at 9 and 10 weeks old), a rota-rod test (at 10 weeks old), a home-cage activity test (at 11 weeks old), a passive avoidance test (at 12 weeks old), a tail suspension test (at 14 weeks old), a hot-plate test (at 15 weeks old), and a tail-fl ick test (at 17 weeks old). If marked phenotypes are detected in behavioral test battery A, detailed analysis chosen from behavioral test battery B will be performed. This may include a prepulse inhibition test (at 10 weeks old), an object exploration test (at 11 weeks old), and a fear conditioning test (at 12 weeks old) (Fig. 3) . For pipeline 2, 30 mice (10 mutant males, 10 heterozygous males, and 10 controls) are required. Only male mice are used for behavioral screening in order to eliminate any effects of the estrous cycle.
Mouse Husbandry and Animal Welfare
Mouse husbandry is regulated by the SOPs of the facility at the Japan Mouse Clinic. The clinic mice are reared in standard laminar-fl ow cage racks, except for newly introduced mice, which are isolated in closed laminar-fl ow cage racks in quarantine rooms. Before beginning phenotype analysis, mice are reared individually in mouse mini-cages starting at 5 weeks of age. A specifi c quantity of autoclaved Paper-Clean chips (Japan SLC) is placed in the cages as bedding. A radiationsterilized diet for rodents (Japan CLEA: CE-2) and ul- 2) Open-fi eld test. The openfi eld test is carried out in order to asses spontaneous activity in a novel environment.
3) Rota-rod test. The rota-rod test is assessment of motor coordination and motor learning ability. 4) Home-cage activity test. The home-cage activity test assesses spontaneous locomotor activity and activity pattern in the home-cage. 5 ) Passive avoidance test. The passive avoidance test is conducted for high throughput assessment learning ability for and memory. 6) Tail suspension test. The tail suspension test is carried out to assess depressive behavior. 7) Hot-plate test. The hot-plate test assesses sensitivity to pain involving the upper central nervous system. 8) Tail-fl ick test. The tail-fl ick test assesses pain sensitivity involving nociceptive refl ex. 9) Prepulse inhibition test. The prepulse inhibition (PPI test) is generally used to examine dysfunction of the sensory motor gating system. 10) Object exploration test (11w). The object exploration test is carried out in order to assess attention to a novel object.
11) Fear conditioning test (12w). The fear conditioning test is a detailed assessment of fear related learning and memory.
trafi ltered city water in bottles is supplied continuously to the mice (ad libitum feeding). All cages and water bottles are changed weekly. Equipment and materials are brought into the mouse housing area using autoclave sterilization, formalin fumigation, or an UV/ozone generator pass-box. All animal caretakers change into autoclaved garments, gloves, and socks in locker rooms before passing through an air shower to the mouse area.
All activities in the mouse clinic are carried out based on the 3Rs rule of animal welfare, and in accordance with the guidelines for the experimental use and care of laboratory animals of the RIKEN Tsukuba Institute. The physical environment of the facility is strictly controlled for refi nement in animal experiments, and the mice are reared under specifi c pathogen-free conditions. The mice are cared for and managed by skillful technicians, and are used properly in experiments performed by adequately trained technical staff. Depending on the SCAW (Scientist Center for Animal Welfare) categories of pain and stress for each experiment, a humane endpoint is established.
Systematic Introduction and Production of Mice Using Reproductive Technologies
The Japan Mouse Clinic manages the phenotypic analyses of various strains in the mouse facility at RIKEN BRC. The mouse facility is managed under SPF conditions. The introduction of mice to the facility is performed by in vitro fertilization (IVF) using fresh or cryopreserved sperm from one male or cryopreserved embryos. The client might send us only one male of an inbred genetic background, for example C57BL/6J (Fig. 4) .
Technology Development I to Support the Japan Mouse Clinic -Development of Accelerated Construction of Congenic Strains
Using Reproductive TechnologiesMany genetically engineered mutant mice are on mixed 129/Sv and C57BL/6J genetic backgrounds. To reduce genetic background effects on phenotyping, generation of congenic strains is essential. In general, to transfer mutations to a homogenous C57BL/6J background, we backcross mutant mice to C57BL/6J mice for 10 generations. However, using traditional methods (i.e., natural mating), this takes between two and three years. To shorten this period, Ogonuki and Ogura introduced a reproductive technology known as round spermatid injection [16] . This method can reduce the period required to create a congenic mouse strain by roughly half. Furthermore, for investigations requiring whole genome scans of the genetic background of a congenic mouse strain, we have established a rapid detection system utilizing SNP genotyping by TaqMan assay (Fig. 5) .
Technology Development II to Support the Japan Mouse Clinic -Establishment of a Reliable Sperm Freezing/Thawing System for the C57BL/6J StrainMost of our genetically engineered strains are maintained on the C57BL/6J genetic background. However, the fertilization rate of cryopreserved spermatozoa from this strain is very low as compared with other inbred strains, though the cause of this phenomenon is still unclear. We have developed a reliable sperm freezing/ thawing system for the C57BL/6J strain, which is shown elsewhere [18] .
Development of SOPs at the Japan Mouse Clinic
Establishing standard operating procedures (SOPs) as tools for the comprehensive phenotype analysis is essential for mouse functional genomics. This provides reliable measures of the process under investigation, and most importantly, ensures that the results are reproducible across both time and laboratory [14] . For these reasons, SOPs for the entire screen have been developed in the Japan Mouse Clinic program. These SOPs were developed based on the procedures of the European Mouse Phenotyping Resource for Standardized Screens (EMPReSS) style [5, 11] (http://www.brc.riken.jp/lab/ bpmp/SOPs/index_mc.html). The EMPReSS was developed as a robust primary screening platform and a SOP in the Eumorphia Program and is operated in the EUMODIC program. The EMPReSS slim SOPs are annotated using high-level mouse phenotype ontology terms to give a general description of the purpose of the procedure and provide a global summary of all parameters within the SOPs [3] . We plan to frequently exchange information regarding standard operating procedures of mouse phenotyping with EUMODIC and other large-scale related projects [15] .
"Pheno-Pub" System Serving Phenotypic Information
We have developed an application called "PhenoPub", which shows phenotypic information of various mouse resources screened at the Japan Mouse Clinic (http://www.brc.riken.jp/lab/jmc/mouse_clinic/en/mstrain_en.html).
This system has two viewers: the first is the "Phenotypic viewer of the differences among strains" and the second is the "Phenotypic viewer of the differences between genotypes". The former is used to easily access and compare the various strain data regarding an interesting parameter. The viewer displays a graph bar or graphic window and a summary table of all phenotypic data. The latter is used to easily access and understand the phenotypic characteristics of an interesting strain through a comparison between genotypes. An "Analysis group" indicates one experimental group, in which phenotypic differences among subgroups separated by various factors are analyzed with statistical methods. These data are hierarchically shown in the "Summary of the procedure", and "Details of the parameter" windows. In some cases, photographs and movies are added to the results to help understand the phenotypes. In this application, we will develop an integrated mouse phenotype database based on information resources delivered by the Japan Mouse Clinic.
SODP Database
The mouse phenotype data are generated through the execution of SOPs, which are different at each institute; they are greatly influenced by differences among SOPs. Therefore, it is essential to develop an intelligence infrastructure that can easily compare differences among SOPs to integrate phenotype information with high reliability [15] . We have developed the Standardized Description of Operating Procedures (SDOP) format, which provides a framework for the description of mouse phenotyping procedures and enables direct comparison of procedural parameters among different institutions. We have posted the SDOP database to a website to display the mouse phenotyping SOPs at the Japan Mouse Clinic and the EUMODIC (http://www.brc.riken.jp/lab/ bpmp/SDOP/index.html).
Conclusions
The Japan Mouse Clinic is a large-scale phenotyping platform and has a hierarchical structure, consisting of a fundamental pipeline that uses the existing platform, and a second pipeline, which is optimized for more indepth phenotyping assays. In the system, we perform comprehensive and in-depth phenotyping of mouse mutants that are and will be deposited to RIKEN BRC. We expect that existing mouse mutants will be reevaluated as new disease models by identifying novel phenotypes. To contribute to international efforts to standardize mouse phenotype data, we plan to frequently exchange information regarding standard operating procedures (SOPs) of mouse phenotyping with other large-scale related projects, such as EUMODIC [13] , GMC [9, 10] , and the Mouse Phenome Project (MPP) [17] . Finally, we will integrate the information regarding mouse phenotypes and clinical features of human diseases. These steps will enable more objective characterization of mouse mutants, and lead to the development of high value-added mouse resources.
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